Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics (Non-Hormonal Therapy and Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F

Prevalence of gynecological disorders and advancements in pharmaceutical research are factors driving the Global Gynecology Drugs market in the forecast period Read More

UAE Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast and Opportunities, 2019-2029F

Government initiatives to promote healthcare innovation and research are factors driving the UAE Pharmaceuticals Market in the forecast period 2025-2029.Read More

Middle East & Africa Pharmaceuticals Market By Drug Type (Generic Drugs and Branded Drugs), By Product Type (Prescription Drugs and Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Country, Competition, Forecast and Opportunities, 2019-2029F

Prevalence of chronic diseases and increasing healthcare expenditure are factors driving the Middle East & Africa Pharmaceuticals market in the forecast period Read More

Respiratory Syncytial Virus (RSV) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug and Vaccines), By End User (Hospitals and Clinics, Ambulatory Centers, Others), By Region and Competition, 2019-2029F

Growing awareness for RSV therapeutics and robust product pipeline with proven track records to meet unmet demand are factors driving the Global Respiratory Read More

Japan Rare Disease Therapeutics Market By Therapeutic Area (Hematologic Diseases, Cancer, Infectious Diseases, Cardiovascular Diseases, Metabolic Diseases, Endocrine Diseases, Musculoskeletal Diseases, Others), By Route of Administration (Injectable, Oral, Others), By Drug Type (Biologics, Biosimilar, Small Molecules), By Distribution Channel (Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in genetic research and diagnostics are factors driving the Japan Rare Disease Therapeutics Market in the forecast period 2026-2030.Read More

Japan Bone Cancer Treatment Market By Bone Cancer Type (Primary Bone Cancer, Secondary Bone Cancer), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advances in surgical techniques and minimally invasive procedures are factors driving the Japan Bone Cancer Treatment Market in the forecast period 2026-2030.Read More

Japan Large Molecule Drug Substance CDMO Market By Service (Contract Manufacturing, Contract Development), By Source (Mammalian, Microbial, Others), By End User (Biotech Companies, CRO, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing demand for biopharmaceuticals and technological advancements in biotechnology are factors driving the Japan Large Molecule Drug Substance CDMO Market Read More

Japan Lumbar Degenerative Disc Disease Market By Treatment Type (Drug Treatment, Biologics, Others), By Route of Administration (Oral, Injectables, Others), By End User (Hospitals, Specialty Clinic, Academic Research Institutes), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advances in medical technology and minimally invasive surgical techniques are factors driving the Japan Lumbar Degenerative Disc Disease Market in the forecast Read More

Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2019-2029F

Increasing Prevalence of Viral Infections are driving the growth in Global Anti-Viral Drugs Market in the forecast period, 2025-2029.Read More

Egypt Pharmaceutical Market By Type (Pharmaceutical Drugs and Biologics), By Drug Classification (Branded Drugs and Generic Drugs), By Mode of Purchase (Prescription-Based Drugs and Over-the-counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition, Forecast & Opportunities, 2019-2029F

Investment in pharmaceutical infrastructure and increasing prevalence of chronic diseases is expected to drive the Egypt Pharmaceutical Market growth in the Read More

India Anti-Fungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition, Forecast and Opportunities, 2020-2030F

Increasing Prevalence of Fungal Infections is expected to drive the demand of India Anti-Fungal Drugs Market in the forecast period 2026-2030.Read More

United Kingdom Nutraceuticals Market By Application (Functional Beverages, Functional Food, Dietary Supplements), By Form (Liquid, Tablets, Capsules, Powder, Others), By Source (Plant, Animal, Microbial), By Distribution Channel (Online, Hypermarkets/Supermarkets, Pharmacies, Specialty Stores), By Region, By Competition, Forecast & Opportunities, 2019-2029F

Innovative product development and increasing awareness regarding benefits of nutraceuticals are factors driving the United Kingdom Nutraceuticals market in the Read More

Algae Omega-3 Ingredients Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Eicosatetraenoic Acid (EPA), Docosahexaenoic Acid (DHA), EPA/DHA), By Application (Food and Beverages, Dietary Supplements, Pharmaceuticals, Animal Nutrition), By Region and Competition, 2019-2029F

Rising awareness of the profound health benefits associated with omega-3 fatty acids is expected to drive the demand of Global Algae Omega-3 Ingredients Market Read More

United Kingdom Over The Counter Drugs Market By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, By Competition, Forecast & Opportunities, 2019-2029F

Increasing consumer preference for self-medication and expansion of retail pharmacy chains are factors driving the United Kingdom Over The Counter Drugs market Read More

India Over The Counter Drugs Market By Product Type (Cold, Cough & Flu, Vitamins, Minerals & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Launch of new OTC products and increasing awareness for self-medication are factors driving the India Over The Counter Drugs Market in the forecast period Read More

India Generic Drugs Market By Type (Small Molecule Generics and Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations and In-house), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expanding pharmaceutical industry and growing demand for affordable healthcare are factors driving the India Generic Drugs Market in the forecast period Read More

Vietnam Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast and Opportunities, 2019-2029F

Medical tourism and healthcare exports are factors driving the Vietnam Pharmaceuticals Market in the forecast period 2025-2029.Read More

Lung Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy), By Drug Class (Corticosteroids, Bronchodilator, Antimicrobial, Alkylating Agents, Mucolytics), By Region and Competition, 2019-2029F

Rising technological innovations in drug delivery is expected to drive the Global Lung Disease Therapeutics Market in the forecast period 2025-2029.Read More

India Lopinavir & Ritonavir Market By Dosage Form (Tablet, Capsule, Oral Solution), By Dosage (Lopinavir 200mg/ Ritonavir 50mg Co-formulated Tablet, Lopinavir 100mg/ Ritonavir-25mg Co-formulated Capsule, Lopinavir 400mg/ Ritonavir 100mg/ 10ml Oral Solution), By Application (HIV, COVID-19, Hepatitis C, Others), By Distribution Channel (Hospitals & Clinics, Drug Stores/Pharmacies, Online, Others), By Region, Competition, Forecast & Opportunities, 2019-2029F

Rise in the prevalence of HIV/AIDS and growing government initiatives are factors driving the India Lopinavir & Ritonavir Market in the forecast period 2025-2029.Read More

ACE Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Others), By Dosage Form (Oral Tablets, Oral Solutions), By Application (Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Others), By End user (Hospitals, Online Drug Stores, Others), By Region and Competition, 2019-2029F

Growing prevalence of cardiovascular diseases and Increased awareness of hypertension are factors driving the Global ACE Inhibitors Market in the forecast period Read More

   Page 1 of 22 Next